CS-0230 series (Shenzhen Chipscreen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCS-0230 series (Shenzhen Chipscreen)
Drug Alias NameRTK inhibitors (Shenzhen Chipscreen Biosciences)CS-230
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A degraders
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenzhen Chipscreen Biosciences Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A